UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000054646
Receipt number R000062445
Scientific Title Post Market Registry Study of Intracranial Aneurysms Treated with Sugita clip.
Date of disclosure of the study information 2024/10/01
Last modified on 2025/12/13 09:05:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Post Market Registry Study of Intracranial Aneurysms Treated with Sugita clip.

Acronym

Post Market Registry Study of Intracranial Aneurysms Treated with Sugita clip.

Scientific Title

Post Market Registry Study of Intracranial Aneurysms Treated with Sugita clip.

Scientific Title:Acronym

Post Market Registry Study of Intracranial Aneurysms Treated with Sugita clip.

Region

Japan


Condition

Condition

intracranial aneurysm

Classification by specialty

Neurosurgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To verify the performance and safety of Sugita clipping device when implanted in the body for an extended period of time in patients who have undergone intracranial aneurysm clipping using the Sugita clipping device, and to identify possible risk factors

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase IV


Assessment

Primary outcomes

Complete occlusion rate of intracranial aneurysms treated with the Sugita clipping device at 12 months postoperatively

Key secondary outcomes

(1) Evaluation of failure and adverse events up to 60 months postoperatively
(2) Comparison of preoperative mRS and mRS up to 60 months postoperatively
(3) Comparison of preoperative HK and WFNS classification and postoperative mRS for ruptured intracranial aneurysms
(4) Reoperation rate of subject aneurysms up to 60 months postoperatively
(5) Surgical success rate: Complete occlusion rate of cerebral aneurysms within 1 week after surgery Completely occluded rate of cerebral aneurysm within 1 week after surgery


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) Patients (regardless of age and gender) with ruptured or unruptured cerebral aneurysms that can be treated by cerebral aneurysm clipping using this device
(2) Patients who have obtained written consent to participate in this study from the subject or a substitute
(3) Patients who are willing to continue scheduled examinations and tests according to institutional standard of care (3) Patients who are willing to continue scheduled examinations and tests in accordance with institutional standard of care.

Key exclusion criteria

(1) Patients who are participating or will participate in a randomized trial of another drug or device
(2) Patients who are unable to undergo follow-up after cerebral aneurysm clipping according to the standard of care at the study site (e.g., medical condition or overseas residency and inability to return home for follow-up)
(3) Patients who do not meet the Instructions for Use (IFU) criteria for this device:
- Patients with severe allergies to metals or relics
- Patients with infections that may lead to metastasis of infected lesions or septicemia

Target sample size

169


Research contact person

Name of lead principal investigator

1st name Saito
Middle name
Last name Ryuta

Organization

Nagoya University Graduate School of Medicine

Division name

Department of Neurosurgery

Zip code

466-8560

Address

Tsurumai-cho 65, SHowa-ku, Nagoya, Aichi

TEL

052-744-2353

Email

ryuta@med.nagoya-u.ac.jp


Public contact

Name of contact person

1st name Gotoh
Middle name
Last name Shunsaku

Organization

Nagoya University Graduate School of Medicine

Division name

Department of Neurosurgery

Zip code

466-8560

Address

Tsurumai-cho 65, SHowa-ku, Nagoya, Aichi

TEL

052-744-2353

Homepage URL


Email

saku.y.1210@gmail.com


Sponsor or person

Institute

Nagoya University

Institute

Department

Personal name



Funding Source

Organization

MIZUHO Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagoya University Clinical Research Review Committee

Address

Tsurumai-cho 65, Showa-ku, Nagoya, Aichi

Tel

052-744-2423

Email

iga-shinsa@t.mail.nagoya-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2024 Year 10 Month 01 Day

Date of IRB

2024 Year 09 Month 17 Day

Anticipated trial start date

2024 Year 10 Month 01 Day

Last follow-up date

2032 Year 04 Month 30 Day

Date of closure to data entry

2032 Year 06 Month 30 Day

Date trial data considered complete

2032 Year 08 Month 31 Day

Date analysis concluded

2032 Year 12 Month 31 Day


Other

Other related information

Study subjects will be enrolled from the date of surgery until one week before the postoperative examination. The study will be defined as complete when the last enrolled study subject completes the 5-year follow-up examination.


Management information

Registered date

2024 Year 06 Month 12 Day

Last modified on

2025 Year 12 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062445